Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Veracyte Inc
Veracyte Inc logo

VCYT - Veracyte Inc Share News

$46.91 -8.5  -15.3%

Last Trade - 04/03/21

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Style Neutral
Market Cap £2.26bn
Enterprise Value £2.01bn
Revenue £84.6m
Position in Universe 1752nd / 6647
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions VCYT Dividends
All News
All News Reuters News Company Announcements
BRIEF-Veracyte announces publication of new long-term outcome study that reinforces the clinical utility of the Afirma Gene expression classifier
14th Sep '15 News
BRIEF-Veracyte Q2 loss per share $0.35
13th Aug '15 News
BRIEF-Veracyte announces national network agreement with Aetna
25th Jun '15 News
BRIEF-Veracyte files for mixed shelf of up to $125 million - SEC filing
24th Jun '15 News
Veracyte lung cancer test could help avoid some risky biopsies
18th May '15 News
BRIEF-Veracyte Q1 loss per share $0.34
14th May '15 News
BRIEF-Veracyte announces $40 mln private placement
23rd Apr '15 News
BRIEF-Veracyte and GE announce research collaboration
14th Apr '15 News
BRIEF-Veracyte announces Q4 loss $0.36/share
19th Mar '15 News
BRIEF-Veracyte says new data inform optimal use in preoperative thyroid nodule assessment
6th Mar '15 News
BRIEF-Veracyte reports positive coverage policy for afirma gene expression classifier
2nd Dec '14 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.